Form 10-Q/A Moleculin Biotech, Inc. For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Moleculin Biotech (MBRX) Reports Q3 Loss of $0.12/Share
November 21, 2016 7:33 AM ESTMoleculin Biotech (NASDAQ: MBRX) reported Q3 EPS of ($0.12), versus ($0.05) reported last year.
For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.
... More


